EGFR and non-small cell lung carcinoma: Previous studies have shown that mutations in EGFR (such as L858R/T790M or ex19Del) in non-small cell lung cancer (NSCLC) cell lines increase EGFR internalization and inhibit ligand-induced degradation32,33.